Advisor Group Holdings, Inc. Reata Pharmaceuticals Inc Transaction History

Advisor Group Holdings, Inc.

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 21, 2023	SELL	$79.22 - $105.37 $40,006 - $53,211	-505 Reduced 8.54%	5,406 $551,000
Q2 2023 Aug 10, 2023	SELL	$79.22 - $105.37 $186,800 - $248,462	-2,358 Reduced 28.52%	5,911 $602,000
Q1 2023 May 12, 2023	BUY	$30.85 - $93.17 $207,219 - $625,822	6,717 Added 432.8%	8,269 $751,000
Q4 2022 Feb 10, 2023	BUY	$22.15 - $42.11 $33,756 - $64,175	1,524 Added 5442.86%	1,552 $58,000
Q3 2022 Nov 14, 2022	SELL	$19.41 - $36.49 $213 - $401	-11 Reduced 28.21%	28 $0
Q2 2022 Aug 10, 2022	SELL	$20.71 - $36.5 $4,224 - $7,446	-204 Reduced 83.95%	39 $0
Q1 2022 May 04, 2022	SELL	$24.12 - $39.6 $26,459 - $43,441	-1,097 Reduced 81.87%	243 $7,000
Q3 2021 Nov 05, 2021	SELL	$100.0 - $143.02 $34,600 - $49,484	-346 Reduced 20.52%	1,340 $138,000
Q2 2021 Aug 02, 2021	SELL	$78.27 - $151.29 $43,283 - $83,663	-553 Reduced 24.7%	1,686 $240,000
Q1 2021 May 13, 2021	SELL	$94.25 - $132.81 $22,337 - $31,475	-237 Reduced 9.57%	2,239 $223,000
Q4 2020 Feb 10, 2021	BUY	$102.03 - $184.62 $59,993 - $108,556	588 Added 31.14%	2,476 $306,000
Q3 2020 Nov 12, 2020	BUY	$93.53 - $163.34 $161,339 - $281,761	1,725 Added 1058.28%	1,888 $184,000
Q2 2020 Aug 14, 2020	BUY	$126.3 - $176.56 $19,955 - $27,896	158 Added 3160.0%	163 $26,000
Q1 2020 May 18, 2020	BUY	$124.16 - $247.74 $620 - $1,238	5 New	5 $0

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.